Follow COGR on LinkedIn11/19/25Nature
If the AI bubble bursts, what will it mean for research?
The rise in artificial-intelligence technologies is unprecedented, but some predict a stock-market crash that could have knock-on effects for funding and jobs
11/19/25Washington Post, Opinion
Europe’s brain drain is accelerating. America can soak it up.
There’s a huge opportunity in welcoming Europe’s overtaxed, underpaid professional and entrepreneurial classes
11/18/25New York Times, Guest Essay
‘We Lost Our Mission’: Three University Leaders on the Future of Higher Ed
11/18/25NOT-OD-26-007
Reminder of Compliance Requirements for NIH Extramural Recipients Related to Renegotiated Aims, Objectives, Titles, and Abstracts
Reminder to NIH awardees that changes in scope represent new terms and conditions, with which recipients must comply. This reminder applies to grants, cooperative agreements, and other transactions.
11/18/25Inside Higher Ed, COGR quoted
As New Federal Research Funding Resumes, China May Already Be Outspending U.S.
A research advocacy organization says China was projected to outpace America in R&D funding even before Trump retook power. The government shutdown probably didn’t help
11/18/25NOT-OD-26-009
Updated Terms and Conditions of Award – Termination and Compliance with Court Orders
11/18/25Bloomberg Law
Trump Spending Freeze Appeal Complicated by NIH Grant Ruling
A US court’s lifting of President Donald Trump’s government-wide spending freeze stoked concerns months later as appeals judges weighed whether an intervening US Supreme Court ruling complicates the reprieve
11/18/25Axios
NIH cuts impacted 74,000 clinical trial patients: study
The Trump administration's termination of federal research grants earlier this year disrupted about 1 in 30 clinical trials funded by the National Institutes of Health, new research shows.
Washington PostSee also
Trump slashed spending on clinical trials. The toll is starting to become clear.
11/17/25The Chronicle
Are the Deals to Save Research Funding Good for Research?
While some researchers have recouped money by joining lawsuits against the government , these scientists are now rebuilding under widely criticized conditions that were adopted by their institutions. In interviews, some said their faith in the country’s once-steady scientific enterprise is shaken — a disruption no deal can fix. They expressed uncertainty over the National Institutes of Health’s future research budget, and said they’d heard from younger scientists who plan to leave the United States or academe altogether.